Literature DB >> 31415219

Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.

Aurea Simon-Soro1, Michael B Sohn2, John E McGinniss1, Ize Imai1, Melanie C Brown1, Vincent R Knecht1, Aubrey Bailey3, Erik L Clarke3, Edward Cantu4, Hongzhe Li2, Kyle Bittinger5,6, Joshua M Diamond1, Jason D Christie1, Frederic D Bushman3, Ronald G Collman1.   

Abstract

Rationale: The oropharyngeal microbiome is a primary source of lung microbiota, contributes to lower respiratory infection, and is also a driver of oral health.
Objectives: We sought to understand oropharyngeal microbial communities in advanced lung disease, community dynamics after lung transplantation, and ecological features of dysbiosis.
Methods: Oropharyngeal wash samples were obtained from individuals with end-stage disease awaiting transplantation (n = 22) and longitudinally from individuals at 6 weeks, 3 months, and 6 months after transplantation (n = 33), along with healthy control subjects (n = 14). Bacterial 16S and fungal internal transcribed spacer rRNA regions were deep-sequenced, and bacterial community respiratory patterns were imputed from taxonomic composition.
Results: Healthy subjects' oropharyngeal microbiomes showed a gradient of community types reflecting relative enrichment of strictly anaerobic, aerobic, or facultative anaerobic bacteria. Patients with end-stage lung disease showed severe dysbiosis by both taxonomic composition and respiration phenotypes, with reduced richness and diversity, increased facultative and decreased aerobic bacteria, and absence of communities characterized by obligate aerobes. In patients at 6 weeks and 3 months post-transplant, richness and diversity were intermediate between healthy and pretransplant subjects, with near-normal distribution of community types. However, by 6 months post-transplant, oropharyngeal wash resembled the low-diversity facultative-dominated profile of pretransplant subjects. Community ecotype correlated with Candida abundance.Conclusions: End-stage lung disease is associated with marked upper respiratory tract dysbiosis involving both community structure and respiratory metabolism profiles of constituent bacteria. Dynamic changes occur after lung transplantation, with partial normalization early but later appearance of severe dysbiosis similar to pretransplant patients. Aberrant oropharyngeal communities may predispose to abnormal lung microbiota and infection risk both in advanced lung disease and after transplantation.

Entities:  

Keywords:  bacteria; dysbiosis; fungi; lung transplantation; microbiome

Mesh:

Substances:

Year:  2019        PMID: 31415219      PMCID: PMC6945465          DOI: 10.1513/AnnalsATS.201904-299OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  27 in total

1.  Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.

Authors:  Emily S Charlson; Joshua M Diamond; Kyle Bittinger; Ayannah S Fitzgerald; Anjana Yadav; Andrew R Haas; Frederic D Bushman; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2012-07-12       Impact factor: 21.405

2.  Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation.

Authors:  Seok-Mo Heo; Elaine M Haase; Alan J Lesse; Steven R Gill; Frank A Scannapieco
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

3.  Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome.

Authors:  Patricia I Diaz; Bo-Young Hong; Jorge Frias-Lopez; Amanda K Dupuy; Mark Angeloni; Loreto Abusleme; Evimaria Terzi; Effie Ioannidou; Linda D Strausbaugh; Anna Dongari-Bagtzoglou
Journal:  Clin Vaccine Immunol       Date:  2013-04-24

4.  APE: Analyses of Phylogenetics and Evolution in R language.

Authors:  Emmanuel Paradis; Julien Claude; Korbinian Strimmer
Journal:  Bioinformatics       Date:  2004-01-22       Impact factor: 6.937

5.  Disordered microbial communities in the upper respiratory tract of cigarette smokers.

Authors:  Emily S Charlson; Jun Chen; Rebecca Custers-Allen; Kyle Bittinger; Hongzhe Li; Rohini Sinha; Jennifer Hwang; Frederic D Bushman; Ronald G Collman
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease.

Authors:  HeeKuk Park; Jong Wook Shin; Sang-Gue Park; Wonyong Kim
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

7.  Characterization of throat microbial flora in smokers with or without COPD.

Authors:  Wenqi Diao; Ning Shen; Yipeng Du; Ke Qian; Bei He
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-04

8.  Defining the healthy "core microbiome" of oral microbial communities.

Authors:  Egija Zaura; Bart J F Keijser; Susan M Huse; Wim Crielaard
Journal:  BMC Microbiol       Date:  2009-12-15       Impact factor: 3.605

9.  Microbial communities in the respiratory tract of patients with interstitial lung disease.

Authors:  Christian Garzoni; Silvio D Brugger; Weihong Qi; Sarah Wasmer; Alexia Cusini; Philippe Dumont; Meri Gorgievski-Hrisoho; Kathrin Mühlemann; Christophe von Garnier; Markus Hilty
Journal:  Thorax       Date:  2013-08-14       Impact factor: 9.139

10.  Oropharyngeal Microbiota in Frail Older Patients Unaffected by Time in Hospital.

Authors:  Victoria C Ewan; William D K Reid; Mark Shirley; A John Simpson; Steven P Rushton; William G Wade
Journal:  Front Cell Infect Microbiol       Date:  2018-02-20       Impact factor: 5.293

View more
  8 in total

1.  Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.

Authors:  Carter Merenstein; Guanxiang Liang; Samantha A Whiteside; Ana G Cobián-Güemes; Madeline S Merlino; Louis J Taylor; Abigail Glascock; Kyle Bittinger; Ceylan Tanes; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Shantan Reddy; Amy E Baxter; Josephine R Giles; Derek A Oldridge; Nuala J Meyer; E John Wherry; John E McGinniss; Frederic D Bushman; Ronald G Collman
Journal:  mBio       Date:  2021-08-17       Impact factor: 7.786

Review 2.  Pathobiology of frailty in lung disease.

Authors:  Brittany Koons; John R Greenland; Joshua M Diamond; Jonathan P Singer
Journal:  Transl Res       Date:  2020-05-03       Impact factor: 7.012

Review 3.  The lung microbiome in lung transplantation.

Authors:  John E McGinniss; Samantha A Whiteside; Aurea Simon-Soro; Joshua M Diamond; Jason D Christie; Fredrick D Bushman; Ronald G Collman
Journal:  J Heart Lung Transplant       Date:  2021-05-07       Impact factor: 13.569

Review 4.  The lung microbiome: progress and promise.

Authors:  Samantha A Whiteside; John E McGinniss; Ronald G Collman
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

Review 5.  Potential implications of SARS-CoV-2 oral infection in the host microbiota.

Authors:  Zhenting Xiang; Hyun Koo; Qianming Chen; Xuedong Zhou; Yuan Liu; Aurea Simon-Soro
Journal:  J Oral Microbiol       Date:  2020-11-29       Impact factor: 5.474

6.  Signatures of COVID-19 severity and immune response in the respiratory tract microbiome.

Authors:  Carter Merenstein; Guanxiang Liang; Samantha A Whiteside; Ana G Cobián-Güemes; Madeline S Merlino; Louis J Taylor; Abigail Glascock; Kyle Bittinger; Ceylan Tanes; Jevon Graham-Wooten; Layla A Khatib; Ayannah S Fitzgerald; Shantan Reddy; Amy E Baxter; Josephine R Giles; Derek A Oldridge; Nuala J Meyer; E John Wherry; John E McGinniss; Frederic D Bushman; Ronald G Collman
Journal:  medRxiv       Date:  2021-04-05

7.  A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.

Authors:  Sudip Das; Eric Bernasconi; Angela Koutsokera; Daniel-Adrien Wurlod; Vishwachi Tripathi; Germán Bonilla-Rosso; John-David Aubert; Marie-France Derkenne; Louis Mercier; Céline Pattaroni; Alexis Rapin; Christophe von Garnier; Benjamin J Marsland; Philipp Engel; Laurent P Nicod
Journal:  Nat Commun       Date:  2021-04-09       Impact factor: 14.919

Review 8.  Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance.

Authors:  Carter Merenstein; Frederic D Bushman; Ronald G Collman
Journal:  Microbiome       Date:  2022-10-05       Impact factor: 16.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.